AAAAAA
Results: 326-350/568
Authors:
DENOTTER W
HILL FWG
KLEIN WR
KOTEN JW
STEERENBERG PA
DEMULDER PHM
RHODE C
STEWART R
FABER JAJ
RUITENBERG EJ
RUTTEN VPMG
Citation: W. Denotter et al., THERAPY OF BOVINE OCULAR SQUAMOUS-CELL CARCINOMA WITH LOCAL DOSES OF INTERLEUKIN-2 - 67-PERCENT COMPLETE REGRESSIONS AFTER 20 MONTHS OF FOLLOW-UP, Cancer immunology and immunotherapy, 41(1), 1995, pp. 10-14
Authors:
BALLARE C
BARRIO M
PORTELA P
MORDOH J
Citation: C. Ballare et al., FUNCTIONAL-PROPERTIES OF FC-2.15, A MONOCLONAL-ANTIBODY THAT MEDIATESHUMAN-COMPLEMENT CYTOTOXICITY AGAINST BREAST-CANCER CELLS, Cancer immunology and immunotherapy, 41(1), 1995, pp. 15-22
Authors:
LANZA L
PEIRANO L
BOSCO O
CONTINI P
FILACI G
SETTI M
PUPPO F
INDIVERI F
SCUDELETTI M
Citation: L. Lanza et al., INTERFERONS UP-REGULATE WITH DIFFERENT POTENCY HLA CLASS-I ANTIGEN EXPRESSION IN M14 HUMAN-MELANOMA CELL-LINE - POSSIBLE INTERACTION WITH GLUCOCORTICOID HORMONES, Cancer immunology and immunotherapy, 41(1), 1995, pp. 23-28
Authors:
UTTENREUTHERFISCHER MM
HUANG CS
REISFELD RA
YU AL
Citation: Mm. Uttenreutherfischer et al., PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS, Cancer immunology and immunotherapy, 41(1), 1995, pp. 29-36
Authors:
YOUNG MRI
IHM J
LOZANO Y
WRIGHT MA
PRECHEL MM
Citation: Mri. Young et al., TREATING TUMOR-BEARING MICE WITH VITAMIN-D-3 DIMINISHES TUMOR-INDUCEDMYELOPOIESIS AND ASSOCIATED IMMUNOSUPPRESSION, AND REDUCES TUMOR-METASTASIS AND RECURRENCE, Cancer immunology and immunotherapy, 41(1), 1995, pp. 37-45
Authors:
MUNN DH
CHEUNG NKV
Citation: Dh. Munn et Nkv. Cheung, ANTIBODY INDEPENDENT PHAGOCYTOSIS OF TUMOR-CELLS BY HUMAN MONOCYTE-DERIVED MACROPHAGES CULTURED IN RECOMBINANT MACROPHAGE-COLONY-STIMULATING FACTOR, Cancer immunology and immunotherapy, 41(1), 1995, pp. 46-52
Authors:
PIETERSZ GA
LI WJ
SUTTON VR
BURGESS J
MCKENZIE IFC
ZOLA H
TRAPANI JA
Citation: Ga. Pietersz et al., IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF A CHIMERIC ANTI-CD19 ANTIBODY, Cancer immunology and immunotherapy, 41(1), 1995, pp. 53-60
Authors:
BATEMAN WJ
DONNELLAN I
FRASER IA
WONG LS
MORRIS AG
Citation: Wj. Bateman et al., LYMPHOCYTES INFILTRATING COLORECTAL-CANCER HAVE LOW PROLIFERATIVE CAPACITY BUT CAN SECRETE NORMAL LEVELS OF INTERFERON-GAMMA, Cancer immunology and immunotherapy, 41(1), 1995, pp. 61-67
Authors:
BOUGHTON BJ
SIMPSON AW
PHAURE TAJ
BEATTY C
Citation: Bj. Boughton et al., GRAFT-VERSUS-HOST DISEASE FOLLOWING INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER (LAK) CELL IMMUNOTHERAPY IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA IN 2ND COMPLETE REMISSION - AUTOLOGOUS LAK CELLS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION ARE DONOR-DERIVED, Cancer immunology and immunotherapy, 41(1), 1995, pp. 68-70
Authors:
KRAWCZYK CM
VERSTOVSEK S
UJHAZY P
MACCUBBIN D
EHRKE MJ
Citation: Cm. Krawczyk et al., PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE/, Cancer immunology and immunotherapy, 40(6), 1995, pp. 347-357
Authors:
SEO N
EGAWA K
Citation: N. Seo et K. Egawa, SUPPRESSION OF CYTOTOXIC T-LYMPHOCYTE ACTIVITY BY GAMMA DELTA T-CELLSIN TUMOR-BEARING MICE/, Cancer immunology and immunotherapy, 40(6), 1995, pp. 358-366
Authors:
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
WERSALL P
HANSSON LO
MELLSTEDT H
Citation: P. Ragnhammar et al., GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AUGMENTS THE INDUCTION OF ANTIBODIES, ESPECIALLY ANTIIDIOTYPIC ANTIBODIES, TO THERAPEUTIC MONOCLONAL-ANTIBODIES, Cancer immunology and immunotherapy, 40(6), 1995, pp. 367-375
Authors:
HARDY B
GALLI M
RIVLIN E
GOREN L
NOVOGRODSKY A
Citation: B. Hardy et al., ACTIVATION OF HUMAN-LYMPHOCYTES BY A MONOCLONAL-ANTIBODY TO B-LYMPHOBLASTOID-CELLS MOLECULAR-MASS AND DISTRIBUTION OF BINDING-PROTEIN, Cancer immunology and immunotherapy, 40(6), 1995, pp. 376-382
Authors:
BOMBIL F
KINTS JP
HAVAUX X
SCHEIFF JM
BAZIN H
LATINNE D
Citation: F. Bombil et al., A RAT MONOCLONAL ANTI-(HUMAN CD2) AND L-LEUCINE METHYL-ESTER IMPACTS ON HUMAN SCID MOUSE GRAFT AND B-LYMPHOPROLIFERATIVE SYNDROME, Cancer immunology and immunotherapy, 40(6), 1995, pp. 383-389
Authors:
DEGAST GC
HAAGEN IA
VANHOUTEN AA
KLEIN SC
DUITS AJ
DEWEGER RA
VROOM TM
CLARK MR
PHILLIPS J
VANDIJK AJG
DELAU WBM
BAST BJEG
Citation: Gc. Degast et al., CD8 T-CELL ACTIVATION AFTER INTRAVENOUS ADMINISTRATION OF CD3XCD19 BISPECIFIC ANTIBODY IN PATIENTS WITH NON-HODGKIN-LYMPHOMA, Cancer immunology and immunotherapy, 40(6), 1995, pp. 390-396
Authors:
LEONG SPL
ZHOU YM
GRANBERRY ME
WANG TF
GROGAN TM
SPIER C
WHITE R
MEHTA A
LIN AY
Citation: Spl. Leong et al., GENERATION OF CYTOTOXIC EFFECTOR-CELLS AGAINST HUMAN-MELANOMA, Cancer immunology and immunotherapy, 40(6), 1995, pp. 397-409
Authors:
BAXEVANIS CN
GRITZAPIS AD
SPANAKOS G
TSITSILONIS OE
PAPAMICHAIL M
Citation: Cn. Baxevanis et al., INDUCTION OF TUMOR-SPECIFIC T-LYMPHOCYTE RESPONSES IN-VIVO BY PROTHYMOSIN-ALPHA, Cancer immunology and immunotherapy, 40(6), 1995, pp. 410-418
Authors:
SHRAYER D
BOGAARS H
HEARING VJ
MAIZEL A
WANEBO H
Citation: D. Shrayer et al., FURTHER CHARACTERIZATION OF A CLINICALLY RELEVANT MODEL OF MELANOMA METASTASIS AND AN EFFECTIVE VACCINE, Cancer immunology and immunotherapy, 40(5), 1995, pp. 277-282
Authors:
TAITZ A
PETRUZZELLI G
PAK AS
WRIGHT MA
MATTHEWS JP
RASLAN WF
LOZANO Y
YOUNG MRI
Citation: A. Taitz et al., IMMUNE PARAMETERS OF MICE BEARING HUMAN HEAD AND NECK-CANCER, Cancer immunology and immunotherapy, 40(5), 1995, pp. 283-291
Authors:
PALOMARES T
BILBAO P
ALONSOVARONA A
BARBERAGUILLEM E
Citation: T. Palomares et al., THE ADDITION OF INTERLEUKIN-2 TO CYCLOPHOSPHAMIDE THERAPY CAN FACILITATE TUMOR-GROWTH OF B16 MELANOMA, Cancer immunology and immunotherapy, 40(5), 1995, pp. 292-298
Authors:
ADAMS GP
MCCARTNEY JE
WOLF EJ
EISENBERG J
TAI MS
HUSTON JS
STAFFORD WF
BOOKMAN MA
HOUSTON LL
WEINER LM
Citation: Gp. Adams et al., OPTIMIZATION OF IN-VIVO TUMOR TARGETING IN SCID MICE WITH DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV - EFFECTS OF DOSE-ESCALATION AND REPEATED IV ADMINISTRATION, Cancer immunology and immunotherapy, 40(5), 1995, pp. 299-306
Authors:
WIRGUIN I
SUTURKOVAMILOSEVIC L
BRIANI C
LATOV N
Citation: I. Wirguin et al., KEYHOLE LIMPET HEMOCYANIN CONTAINS GAL(BETA-1-3)-GALNAC DETERMINANTS THAT ARE CROSS-REACTIVE WITH THE T-ANTIGEN, Cancer immunology and immunotherapy, 40(5), 1995, pp. 307-310
Authors:
MAHVI DM
MADSEN JA
WITT PL
SONDEL PM
Citation: Dm. Mahvi et al., INTERFERON-ALPHA ENHANCES EXPRESSION OF TAG-72 AND CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH PRIMARY COLORECTAL-CANCER, Cancer immunology and immunotherapy, 40(5), 1995, pp. 311-314
Authors:
LASEK W
WANKOWICZ A
KUC K
FELESZKO W
GOLAB J
GIERMASZ A
WIKTORJEDRZEJCZAK W
JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY MACROPHAGE-COLONY-STIMULATING FACTOR IN A MMB16 MELANOMA MODEL IN MICE, Cancer immunology and immunotherapy, 40(5), 1995, pp. 315-321
Authors:
ROSENBLUM MG
CHEUNG L
MUJOO K
MURRAY JL
Citation: Mg. Rosenblum et al., AN ANTIMELANOMA IMMUNOTOXIN CONTAINING RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR - TISSUE DISPOSITION, PHARMACOKINETIC, AND THERAPEUTIC STUDIES IN XENOGRAFT MODELS, Cancer immunology and immunotherapy, 40(5), 1995, pp. 322-328